Search

Search Constraints

You searched for: Author/Creator Godi, Anna

Search Results

2. Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine. Issue 9 (23rd February 2022)

3. Comprehensive evaluation of the antigenic impact of intra-genotypic human papillomavirus variant diversity on recognition by neutralizing monoclonal antibodies raised against lineage a L1 virus like particles. Issue 7 (10th July 2020)

4. Comprehensive evaluation of the antigenic impact of intra-genotypic human papillomavirus variant diversity on recognition by neutralizing monoclonal antibodies raised against lineage a L1 virus like particles. Issue 7 (10th July 2020)

5. Comprehensive evaluation of the antigenic impact of intra-genotypic human papillomavirus variant diversity on recognition by neutralizing monoclonal antibodies raised against lineage a L1 virus like particles. Issue 7 (10th July 2020)

6. Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine. Issue 18 (24th April 2019)

7. Impact of naturally occurring variation in the human papillomavirus 52 capsid proteins on recognition by type-specific neutralising antibodies. (18th January 2019)

8. Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies. (13th June 2018)